2型心肌梗死与心肌损伤患者的长期结局
该研究在三级心脏中心连续纳入2122例肌钙蛋白I升高(≥0.05 µg/L)患者,按通用定义裁定为1型心梗、2型心梗或心肌损伤。5年时2型心梗(62.5%)和心肌损伤(72.4%)的全因死亡 rate 高于1型心梗(36.7%),超额死亡主要源于非心血管原因;但粗重大心血管不良事件率相似,调整后2型心梗/心肌损伤组更低;冠心病是重大心血管不良事件的独立预测因素。
要点
- 2型心梗和心肌损伤患者5年全因死亡风险显著高于1型心梗,超额死亡以非心血管原因为主。
- 粗重大心血管不良事件率在2型心梗/心肌损伤与1型心梗间相似,调整协变量后2型心梗/心肌损伤组更低。
- 冠心病是2型心梗或心肌损伤患者发生重大心血管不良事件的独立预测因素。
核心结论
- 2型心肌梗死或心肌损伤患者非心血管死亡超额,但粗重大心血管不良事件率与1型心肌梗死相似。
- 识别该人群中的潜在冠心病可能有助于靶向治疗以改变未来风险。
研究设计与样本
- 连续纳入三级心脏中心2122例肌钙蛋白I≥0.05 µg/L的患者,按心肌梗死通用定义裁定诊断。
- 主要结局为全因死亡,次要结局包括重大心血管不良事件和非心血管死亡,采用Cox回归模型分析病因特异性风险比。
主要发现
- 裁定诊断:1型心梗1171例(55.2%),2型心梗429例(20.2%),心肌损伤522例(24.6%)。
- 5年全因死亡率:2型心梗62.5%,心肌损伤72.4%,1型心梗36.7%。
- 2型心梗或心肌损伤组非心血管死亡风险高于1型心梗(HR 2.32,95%CI 1.92-2.81)。
- 粗重大心血管不良事件率两组相似(30.6% vs 32.6%),调整协变量后HR 0.82(95%CI 0.69-0.96)。
- 冠心病是2型心梗或心肌损伤患者重大心血管不良事件的独立预测因素(HR 1.71,95%CI 1.31-2.24)。
临床怎么用
- 对2型心梗或心肌损伤患者应关注非心血管合并症及死亡风险。
- 评估潜在冠心病有助于识别重大心血管不良事件高危患者并指导靶向治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Type 2 myocardial infarction and myocardial injury are common in clinical practice, but long-term consequences are uncertain. We aimed to define long-term outcomes and explore risk stratification in patients with type 2 myocardial infarction and myocardial injury. METHODS: We identified consecutive patients (n=2122) with elevated cardiac troponin I concentrations (≥0.05 µg/L) at a tertiary cardiac center. All diagnoses were adjudicated as per the universal definition of myocardial infarction. The primary outcome was all-cause death. Secondary outcomes included major adverse cardiovascular events (eg, nonfatal myocardial infarction or cardiovascular death) and noncardiovascular death. To explore competing risks, cause-specific hazard ratios were obtained using Cox regression models. RESULTS: The adjudicated index diagnosis was type 1 or 2 myocardial infarction or myocardial injury in 1171 (55.2%), 429 (20.2%), and 522 (24.6%) patients, respectively. At 5 years, all-cause death rates were higher in those with type 2 myocardial infarction (62.5%) or myocardial injury (72.4%) compared with type 1 myocardial infarction (36.7%). The majority of excess deaths in those with type 2 myocardial infarction or myocardial injury were because of noncardiovascular causes (hazard ratio, 2.32; 95% confidence interval, 1.92-2.81 versus type 1 myocardial infarction). Despite this finding, the observed crude major adverse cardiovascular event rates were similar between groups (30.6% versus 32.6%), with differences apparent after adjustment for covariates (hazard ratio, 0.82; 95% confidence interval, 0.69-0.96). Coronary heart disease was an independent predictor of major adverse cardiovascular events in those with type 2 myocardial infarction or myocardial injury (hazard ratio, 1.71; 95% confidence interval, 1.31-2.24). CONCLUSIONS: Despite an excess in noncardiovascular death, patients with type 2 myocardial infarction or myocardial injury have a similar crude rate of major adverse cardiovascular events as those with type 1 myocardial infarction. Identifying underlying coronary heart disease in this vulnerable population may help target therapies that could modify future risk.
引用
- Chapman AR, Shah ASV, Lee KK, et al. Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury. Circulation. 2017. PMID: 29150426. doi:10.1161/CIRCULATIONAHA.117.031806
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。